Document Detail


Increased prevalence of pervasive developmental disorders in children with slight arylsulfatase A deficiency.
MedLine Citation:
PMID:  12427515     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Arylsulfatase A deficiency (less than 15% of controls) is responsible for a neurological disorder known as metachromatic leukodystrophy. Nonetheless, low levels of the enzyme (15-50% of controls, higher than in metachromatic leukodystrophy) in adult patients have been related to neuropsychiatric disorders. On the other hand, there are only few and controversial data on the significance of reduced arylsulfatase A activity in children. This led us to perform the present study. Various classes of arylsulfatase A activity in children have been related with different groups of neuropsychiatric disorders and compared with a similar number of healthy children. We found a high percentage of reduced arylsulfatase A (less than 50% of controls) in children with pervasive developmental disorders (10.25%). Unexpectedly, raising the threshold level for considering arylsulfatase A deficiency up to 70% of controls resulted in a marked increase in the incidence of pervasive developmental disorders. This new class, arylsulfatase A slight deficiency, contained the highest number of patients affected by psychiatric symptoms. This suggests that arylsulfatase A slight deficiency could be a marker of a subclass of pervasive developmental disorders.
Authors:
Maria Grazia Alessandri; Giuseppe De Vito; Francesco Fornai
Related Documents :
1405545 - The clinical utility of the p3 aerp in children with auditory processing disorders.
12788245 - Family psychoeducation: an adjunctive intervention for children with bipolar disorder.
2817955 - Gowers' sign revisited.
21190115 - A rare presentation of crush injury: transanal small bowel evisceration. case report an...
16702095 - Prosodic and lexical aspects of maternal linguistic input to late-talking toddlers.
4045685 - Refining personality assessments by combining mcmi high point profiles and mmpi codes, ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Brain & development     Volume:  24     ISSN:  0387-7604     ISO Abbreviation:  Brain Dev.     Publication Date:  2002 Oct 
Date Detail:
Created Date:  2002-11-12     Completed Date:  2003-01-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7909235     Medline TA:  Brain Dev     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  688-92     Citation Subset:  IM    
Copyright Information:
Copyright 2002 Elsevier Science B.V.
Affiliation:
Division of Child Neurology and Psychiatry, IRCCS Stella Maris, Via dei Giacinti 2, I-56018 Calambrone, Pisa, Italy. mariagrazia.alessandri@inpe.unipi.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Cerebroside-Sulfatase / deficiency*
Child
Child Development Disorders, Pervasive / enzymology*,  epidemiology,  etiology*
Child, Preschool
Female
Humans
Infant
Male
Prevalence
Chemical
Reg. No./Substance:
EC 3.1.6.8/Cerebroside-Sulfatase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Abnormalities in event-related potential and brainstem auditory evoked response in children with noc...
Next Document:  Cerebral hemodynamics during early neonatal period in preterm infants with periventricular leukomala...